Search

Willeke Van Eeckhoutte shares her thoughts and hopes on International Day of Persons with Disabilities (IDPD).

In usual times, MS Ireland’s network of Regional Community Workers would arrange a programme locally for those who have recently received a diagnosis of MS. This programme normally aims to give people newly diagnosed with MS information and tools to help them navigate their new diagnosis.

While physical events were not possible for the majority of 2020, we recognise that this programme is still essential for those newly diagnosed with MS. In November 2020, the North Dublin and Fingal Region arranged a virtual Newly Diagnosed Programme which was facilitated on Zoom.

Willeke Van Eeckhoutte looks at the important contribution and benefits of volunteering. 

MS Ireland, as part of the Neurological Alliance of Ireland (NAI) recently took part in a meeting with Minister of State for Disabilities Anne Rabbitte. 

This year, we have some additional challenges over the winter months, so it’s especially important to be prepared.

Researchers at Trinity College Dublin and Beaumont Hospital are carrying out a study exploring cognitive changes (thinking and memory) in Multiple Sclerosis.

Robert Joyce shares his opinion on what he would like to see the Government address in the upcoming budget.

Ocrevus (ocrelizumab) is the first and only licensed treatment for people with early, inflammatory primary progressive multiple sclerosis in Ireland.

Dublin, 1st of October 2020 – Roche Products (Ireland) Ltd. (“Roche”), today, announced that OCREVUS® (ocrelizumab) is now publicly available in Ireland to treat people living with primary progressive multiple sclerosis (PPMS). More than 9,000 people in Ireland are living with MS(1) and it is estimated that PPMS, a highly disabling form of MS, and according to MS Ireland, affects approximately 15% of people diagnosed with MS(1).

Today, October 6th marks the first ever European Carers Day. Mary Devereux shares her thoughts on why carers need more care.